HomeNewsIndiaRising awareness and COVID-19 impact: India's private health insurers see 26% premium surge in August

Rising awareness and COVID-19 impact: India's private health insurers see 26% premium surge in August

Analysts cite low COVID-related policy renewals from last year as a reason for the high base this year

September 09, 2023 / 08:51 IST
Story continues below Advertisement
..
The health insurance sector in India is witnessing robust growth, driven by increased awareness, rising medical costs, and evolving consumer behaviour influenced by the pandemic

Standalone private health insurers in India continued their growth in gross underwritten premiums in August, according to the latest data.

In the recently reported August period, their gross underwritten premium surged by 26 percent year-on-year (YoY), reaching a total of Rs 2,591 crore, according to provisional data released by the General Insurance Council.

Story continues below Advertisement

Sequentially, the numbers were low from the record high of Rs 2665 crore in July. This surge in premium collections can be attributed to several factors, including heightened awareness about health insurance following the pandemic. Despite this growth, experts believe that India still faces a significant underinsurance problem.

"A large part of the population, even the population that can afford health insurance, remains out of medical coverage in India," said an analyst who did not wish to be named, citing his firm's confidentiality policy.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show